Get our best money-saving hacks and pro tips now

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

53.22

+0.61

(+1.16%)

At close: 04:00PM EDT

53.29

+0.07

(+0.13%)

After hours:

05:46PM EDT

Loading interactive chart…

Zacks
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog.
Motley Fool
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Sanofi and Regeneron's mega-blockbuster drug could soon be approved in the U.S. for yet another indication.
Motley Fool
Is Sanofi Stock a Buy Now?
French pharmaceutical giant Sanofi (NASDAQ: SNY) has long been a leader in the market for insulin. First, Sanofi was forced to decrease the price of its most prescribed insulin product after its only two real competitors in this area did something similar. Second, Sanofi announced the acquisition of Provention Bio, a biotech focusing on developing medicines to delay or prevent the onset of autoimmune diseases, such as Type 1a diabetes.